School of Medicine and Public Health, College of Health, Medicine and Wellbeing, Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Dept of Pharmaco-Therapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands.
Eur Respir Rev. 2022 Jun 14;31(164). doi: 10.1183/16000617.0039-2022. Print 2022 Jun 30.
Conflicting literature exists regarding the risk factors for exacerbations among pregnant women with asthma. This systematic review and meta-analysis aimed to determine risk factors for asthma exacerbations during pregnancy.
Electronic databases were searched for the following terms: (asthma or wheeze) and (pregnan* or perinat* or obstet*) and (exacerb* or flare up or morbidit* or attack*).All studies published between 2000 and 24 August 2021 were considered for inclusion if they reported at least one potential risk factor of asthma exacerbations in pregnant women with asthma. Of the 3337 references considered, 35 publications involving 429 583 pregnant women with asthma were included. Meta-analyses were conducted to determine mean difference in risk factor between exacerbation groups, or the relative risks of exacerbation with certain risk factors. Good study quality was found through the Newcastle-Ottawa Scale (median score 8, interquartile range 7-9).
Increased maternal age (mean difference 0.62, 95% CI 0.11-1.13), obesity (relative risk 1.25, 95% CI 1.15-1.37), smoking (relative risk 1.35, 95% CI 1.04-1.75), black ethnicity (relative risk 1.62, 95% CI 1.52-1.73), multiparity (relative risk 1.31, 95% CI 1.01-1.68), depression/anxiety (relative risk 1.42, 95% CI 1.27-1.59), moderate-severe asthma (relative risk 3.44, 95% CI 2.03-5.83, mild) and severe asthma (relative risk 2.70, 95% CI 1.85-3.95, mild-moderate) were associated with an increased risk of asthma exacerbations during pregnancy.
Future interventions aimed at reducing exacerbations in pregnancy could address the modifiable factors, such as smoking and depression/anxiety, and introduce more regular monitoring for those with nonmodifiable risk factors such as obesity and more severe asthma.
关于哮喘孕妇加重的风险因素,文献存在冲突。本系统评价和荟萃分析旨在确定怀孕期间哮喘加重的风险因素。
电子数据库中检索了以下术语:(哮喘或喘息)和(妊娠或围产期或产科)和(加重或恶化或发病率或发作)。如果报告了至少一种哮喘孕妇加重的潜在风险因素,则考虑纳入 2000 年至 2021 年 8 月 24 日期间发表的所有研究。共纳入 35 项研究,涉及 429583 名哮喘孕妇。进行荟萃分析以确定加重组之间风险因素的平均差异,或某些风险因素加重的相对风险。通过纽卡斯尔-渥太华量表(中位数 8 分,四分位距 7-9 分)发现研究质量良好。
母亲年龄增加(平均差异 0.62,95%CI 0.11-1.13)、肥胖(相对风险 1.25,95%CI 1.15-1.37)、吸烟(相对风险 1.35,95%CI 1.04-1.75)、黑种人(相对风险 1.62,95%CI 1.52-1.73)、多胎(相对风险 1.31,95%CI 1.01-1.68)、抑郁/焦虑(相对风险 1.42,95%CI 1.27-1.59)、中重度哮喘(相对风险 3.44,95%CI 2.03-5.83,轻度)和重度哮喘(相对风险 2.70,95%CI 1.85-3.95,轻度-中度)与怀孕期间哮喘加重的风险增加相关。
未来旨在减少怀孕期间加重的干预措施可以针对可改变的因素(如吸烟和抑郁/焦虑),对于肥胖和更严重的哮喘等不可改变的风险因素,引入更定期的监测。